Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CLO test results

16 Sep 2009 07:30

RNS Number : 1252Z
T2 Income Fund Limited
16 September 2009
 

T2 Income Fund Limited ("T2" or the "Company")

Monthly CLO Test Results

The Company announces the test results as of 2 September 2009 pursuant to the indenture of the Company's subsidiary, T2 Income Fund CLO I Ltd (the "CLO"). The report summarising the results of those tests can be found at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/1252Z_-2009-9-15.pdf

With respect to the various tests required under the CLO indenture, on 14 September 2009, the CLO passed all collateral coverage tests and all of the loans held within the CLO continue to pay the interest due. 

It should be noted that the implications of failing the collateral coverage tests are very complicated, and the consequences could include interest diversion, principal repayment, or limitations on reinvestment of available cash balances. 

Distinct from the collateral coverage tests are the percentage limitation tests. The consequence of failing these percentage limitation tests is simply that each new investment made by the CLO must "maintain or improve" the test result.

The CLO failed four portfolio percentage limitation tests, two of which relate to limitations on loans rated CCC+/Caa1 and lower by S&P and Moody's, respectively, one related to the highest single obligor for non-senior secured loans and one related to the minimum percentage of senior secured loans required to be outstanding.

The failure of the senior secured loan minimum percentage was due to the amount of cash held within the CLO ($32.1 million); cash is excluded when calculating the percentage of senior secured loans. The Company believes that the substantial cash balance provides an opportunity to acquire better-rated securities at discounts to their par value, which should help to improve the quality of the portfolio as well as improve the CLO's collateral test coverage ratios under a variety of scenarios. As cash is invested in new senior secured loans, this failure should be cured automatically. Although no new investments rated CCC+/Caa1 or lower have been made by the manager for some time, the failure of CCC+/Caa1 percentage limitations tests occurred due to historic and ongoing downgrades of companies by S&P and Moody's. The manager continues to evaluate opportunities to reduce the amount of these loans in situations where a sale could be achieved without incurring substantial principal losses.

The failure of the highest single obligor for non-senior secured ("second lien") loans percentage was due to the sale of certain loans at the CLO's option in August , due to credit concerns, at a realized loss, which reduced the aggregate collateral balance from approximately $303 million in July 2009 to $297 million in August 2009. Since there is a single non-senior secured loan of $9.0 million currently outstanding, the 3.0% maximum limit percentage was violated. However, this specific test is a "maintain and improve" covenant and thus does result in interest diversion or principal paydown.

These covenant violations described above do not have a material impact on the CLO's ability to invest in new loans, and all of the loans held within the CLO continue to pay the interest due.

The next payment test date is 2 October 2009. While we continue to monitor the situation closely, we currently have only limited visibility with respect to which of the CLO tests may or may not be met on that date or other future dates, and whether any further principal paydowns or interest diversions may occur and, if so, the magnitude of those paydowns or diversions.  

While the current month's test results are not controlling as to the 2 October 2009 payment test, it may be worth noting that, had this been a payment test, there would not have been an interest diversion.

As described in previous press releases, the CLO indenture contains a variety of covenants, compliance with which could be made more difficult or impossible should credit markets deteriorate or the loans held by the CLO fail to make expected payments or otherwise not perform.

Contacts:

Geoffrey MillerT2 Income Fund Limited+353 1 4433 466

Patrick ConroyT2 Income Fund Limited+1 203 983 5282

Philip SecrettNominated AdviserGrant Thornton UK LLP+44 (0) 20 7383 5100

Jos TrustedSinger Capital Markets Limited +44 (0) 20 3205 7622

Ed Gascoigne PeesFinancial Dynamics+44 (0) 20 7269 7132

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIFFFLASIELIA
Date   Source Headline
15th Oct 20107:00 amRNSCLO test results
24th Sep 20107:00 amRNSUnaudited Interim Results 2010
16th Sep 20107:00 amRNSCLO Test Results and Ratings Upgrade
18th Aug 201012:10 pmRNSChange of Designated Manager and Administrator
18th Aug 20107:00 amRNSNAV Update and Acquisition from CLO
16th Aug 20107:00 amRNSCLO Test Results
13th Aug 201012:50 pmRNSHolding(s) in Company
2nd Aug 201010:42 amRNSChange of Registered Office
22nd Jul 20107:00 amRNSAnnouncement of Dividend
19th Jul 20107:00 amRNSQuarterly CLO Test Results
16th Jun 20107:00 amRNSCLO Test Results
19th May 20107:00 amRNSNAV Update for the quarter ended 31 March 2010
14th May 20107:00 amRNSCLO Test Results
13th May 201010:55 amRNSHolding(s) in Company
28th Apr 201012:33 pmRNSResult of AGM
28th Apr 20107:00 amRNSAGM Statement
22nd Apr 201010:18 amRNSAnnouncement of Dividend
16th Apr 20107:00 amRNSQuarterly CLO Test Results
9th Apr 20104:14 pmRNSNotice of AGM
26th Mar 20106:25 pmRNSFull Year Results 2009 - Replacement
26th Mar 20108:45 amRNSInvestment Manager Agreement Variation
26th Mar 20107:00 amRNSFull Year Results 2009
18th Mar 20107:00 amRNSNotice of Results
15th Mar 20107:00 amRNSCLO Test Results
26th Feb 20107:00 amRNSQuarterly Net Asset Value Update
15th Feb 20107:00 amRNSCLO Test Results
4th Feb 20102:50 pmRNSHolding(s) in Company
1st Feb 201010:20 amRNSDealing by Investment Manager
21st Jan 20107:00 amRNSTrading Update and Dividend Announcement
18th Jan 20107:00 amRNSQuarterly CLO Test Results
11th Jan 20103:15 pmRNSHolding(s) in Company
8th Jan 20102:42 pmRNSHolding(s) in Company
21st Dec 20097:00 amRNSAcquisition of Investment
14th Dec 20097:00 amRNSCLO Test Results
9th Dec 200912:10 pmRNSHolding(s) in Company
17th Nov 20097:00 amRNSCLO Test Results
13th Nov 20092:15 pmRNSQuarterly Net Asset Value Update
30th Oct 20099:28 amRNSHolding(s) in Company
29th Oct 20095:25 pmRNSDirector/PDMR Shareholding - Replacement
29th Oct 20094:25 pmRNSDirector/PDMR Shareholding
26th Oct 200911:20 amRNSChange of Name
23rd Oct 200910:50 amRNSExercise of Options
22nd Oct 20092:15 pmRNSDealing by Investment Manager
22nd Oct 20099:15 amRNSHolding(s) in Company
22nd Oct 20099:00 amRNSTotal Voting Rights
21st Oct 20092:56 pmRNSHolding(s) in Company
20th Oct 20095:42 pmRNSHolding(s) in Company
16th Oct 200912:35 pmRNSResult of EGM
16th Oct 20097:00 amRNSCLO test results
14th Oct 20097:00 amRNSResult of proposed placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.